Search Results 521-530 of 12273 for ڸӴƮ

1. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. MEVOKED and PHQ9 Data - Mayo Clinic

   This study will obtain additional information on participants – in particular PHQ9 depression scores and medication use during their enrollment in the MEVOKED ...

3. Evaluating Kidney Stones To Determine If They Lead to Kidney Disease - Mayo Clinic

   About this study. We hypothesize that clinical studies to investigate the role of individual proteins in kidney stone pathogenesis have likely been ...

4. A Study to Evaluate the Safety and Effectiveness of Lanadelumab to Prevent Acute Attacks of Non-histaminergic Angioedema - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Azacitidine and Sonidegib in Treating Patients With Myeloid Malignancies - Mayo Clinic

   The hedgehog (Hh) signaling pathway plays an important role in cellular growth, differentiation and repair. Inappropriate activation of Hh pathway signaling and ...

6. A Study of Biofluids in Parkinson Disease and Related Disorders - Mayo Clinic

   The purpose of this study is to analyze DNA and genome-wide analyses, as well as metabolomics and biomarker studies, from patients in the spectrum clinically ...

7. Pulmonary Hypertension and Chronic Kidney Disease - Mayo Clinic

   The aims of this study are to establish a registry and biorepository of patients with PH-CKD, and to identify clinical risk factors and biomarkers associated ...

8. A Study to Evaluate Shoulder Anthroplasty Outcomes - Mayo Clinic

   The primary objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data to better understand the safety and performance ...

9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

   A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With ...

10. Staging of Superficial EAC Using VLE - Mayo Clinic

    This study is being done to see if the NvisionVLE Imaging System can accurately determine the diagnostic performance of staging of T1 esophageal adenocarcinoma.